• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Catalog Number BXA077902E
Device Problem Collapse (1099)
Patient Problem No Code Available (3191)
Event Date 03/25/2020
Event Type  Injury  
Manufacturer Narrative
The physician was contacted to provided additional information, for example the lot numbers.Intra- and postprocedural images were also requested for evaluation.The device remains implanted in the patient.So no engineering evaluation could be performed.The delivery system was discarded at the facility.So no engineering evaluation could be performed.The event involves three devices reported under mfr report numbers #2017233-2020-00272 and #2017233-2020-00273.
 
Event Description
It was reported, that the patient underwent a covered endovascular reconstruction of aortic bifurcation (cerab) with "kissing-stent" technique in both iliac arteries using atrium advanta¿ v12 balloon expandable covered stents (getinge) some weeks ago.Control angiography imaging showed complete collapse of the advanta¿ v12 stent.It was stated, that they were almost flat.Therefore, on (b)(6) 2020, the patient underwent a reintervention to reline the collapsed advanta¿ v12 stents in both iliac arteries with three gore® viabahn® vbx balloon expandable endoprostheses (viabahn® vbx endoprostheses, sizes: 9 mm x 39 mm, 7 mm x 79 mm and 7 mm x 79 mm) using a "kissing-stent" technique.Reportedly, the physician recanalized one of the collapsed advanta¿ v12 stents and passed the others collapsed advanta¿ v12 stents subintimal to place the viabahn® vbx endoprostheses.It was stated, that a control computed tomography angiography one week post implantation showed good results.Reportedly, on (b)(6) 2020, the patient presented with pain.A computed tomography angiography showed that all three viabahn® vbx endoprostheses collapsed.It was reported, that they were almost flat.It was reported, that the patient suffered from high grade constipation.It was stated, that the physician indicated that this may result in extremely high abdominal pressure.Reportedly, the physician has said, that the collapses were not device related.Reportedly, an additional endovascular reintervention is planned to treat the collapsed viabahn® vbx endoprostheses.
 
Manufacturer Narrative
H6-code 50: extremely high abdominal pressure.
 
Manufacturer Narrative
The event involves three devices, reported under mfr report numbers #2017233-2020-00272, #2017233-2020-00273 and #2017233-2020-00274.Updated event description.Updated device information.Updated device information.Code 213: a review of the manufacturing records indicated these lots met pre-release specifications code 4111: several attempts were made to obtain additional information from the physician.The requests remain unanswered.Without additional information, gore was unable to do further investigation of this event.
 
Event Description
It was reported, that the patient underwent a covered endovascular reconstruction of aortic bifurcation (cerab) with "kissing-stent" technique in both iliac arteries using atrium advanta¿ v12 balloon expandable covered stents (getinge) some weeks ago.Control angiography imaging showed complete collapse of the advanta¿ v12 stent.It was stated, that they were almost flat.Therefore, on (b)(6) 2020, the patient underwent a reintervention to reline the collapsed advanta¿ v12 stents in both iliac arteries with three gore® viabahn® vbx balloon expandable endoprostheses (viabahn® vbx endoprostheses, sizes: 9 mm x 39 mm, 7 mm x 79 mm and 7 mm x 79 mm) using a "kissing-stent" technique.Reportedly, the physician recanalized one of the collapsed advanta¿ v12 stents and passed the others collapsed advanta¿ v12 stents subintimal to place the viabahn® vbx endoprostheses.It was stated, that a control computed tomography angiography one week post implantation showed good results.Reportedly, on (b)(6) 2020, the patient presented with pain.A computed tomography angiography showed that all three viabahn® vbx endoprostheses collapsed.It was reported, that they were almost flat.It was reported, that the patient suffered from high grade constipation.It was stated, that the physician indicated that this may result in extremely high abdominal pressure.Reportedly, the physician has said, that the collapses were not device related.Reportedly, an additional endovascular reintervention is planned to treat the collapsed viabahn® vbx endoprostheses.
 
Manufacturer Narrative
D2: corrected common device name.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9999174
MDR Text Key193939227
Report Number2017233-2020-00274
Device Sequence Number1
Product Code PRL
Combination Product (y/n)N
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup,Followup
Report Date 07/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/21/2022
Device Catalogue NumberBXA077902E
Device Lot Number20781111
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/25/2020
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Supplement Dates FDA Received05/28/2020
05/28/2020
07/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age59 YR
-
-